Somnomed Ltd
ASX:SOM

Watchlist Manager
Somnomed Ltd Logo
Somnomed Ltd
ASX:SOM
Watchlist
Price: 0.59 AUD -0.84% Market Closed
Market Cap: 127.5m AUD

Somnomed Ltd
Investor Relations

SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. The company is headquartered in Sydney, New South Wales. The company went IPO on 2004-08-27. The firm provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. SomnoMed has developed the SomnoDent, a collection of oral devices. SomnoDent includes two product line, such as signature line and standard line. Its signature line products include Herbst Advance Elite, Fusion, Flex and Classic, and standard line products include Herbst Advance, Air/Air+, Morning Repositioner and Alpha. SomnoMed has developed the SomnoBrux, a custom fit acrylic occlusal splint. SomnoBrux product includes Michigan. SomnoMed has developed the SomGauge, is an autoclavable instrument, which can be used to construct accurate and reliable bite records.

Show more
Loading
SOM
S&P/ASX 300
1Y 3Y 5Y 10Y 15Y 20Y

Earnings Calls

No Earnings Calls Available

Management

Ms. Karen Borg B.A.
Co-CEO & Executive Director
No Bio Available
Mr. Mark Harding
Vice President of Global Marketing
No Bio Available
Mr. Matthew Conlon
Executive VP of Sales & Marketing - North America
No Bio Available
Mr. Marco Van Kleef
Vice President of Marketing & Sales - Europe
No Bio Available
Ms. Ye-Fei Guo
Chief Financial Officer
No Bio Available
Mr. Terence A. Flitcroft B.Com., B.Comm., C.A., SF FIN
Company Secretary
No Bio Available
Mr. Christopher Bedford
Vice President of Global Production and Product Development
No Bio Available

Contacts

Address
NEW SOUTH WALES
Sydney
L 3 20 Clarke St, Crows Nest
Contacts
+61294670400.0
somnomed.com
sparklesyt

See Also

Summary
SOM intrinsic value, competitors valuation, and company profile.
DCF Valuation
SOM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SOM stock valuation using valuation multiples.
Wall Street Estimates
SOM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SOM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 242,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.